22 May 2013
Keywords: Sanofi-Aventis, Ciltyri, FDA approval, Insomnia
Article | 17 September 2009
The US Food and Drug Administration has issued a complete response letter regarding the French drug major Sanofi-Aventis's New Drug ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
17 September 2009
21 May 2013
© 2013 thepharmaletter.com